Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
November 07 2023 - 4:15PM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced that the Company will participate in the following
investor conferences in New York, NY:
-
Stifel 2023 Healthcare
ConferenceQuestion-and-answer session with analyst on
Wednesday, November 15th at 10:55 a.m. ET
-
Canaccord Genuity Medtech, Diagnostics and Digital Health
& Services ForumCompany presentation on Thursday,
November 16th at 8:00 a.m. ET
Live webcasts for both events will be available
on the Rapid Micro Biosystems investor relations website at
https://investors.rapidmicrobio.com/ and can be accessed here. The
webcasts will be archived and available for replay after the
events.
About Rapid Micro
Biosystems
Rapid Micro Biosystems is an innovative life
sciences technology company providing mission critical automation
solutions to facilitate the efficient manufacturing and fast, safe
release of healthcare products such as biologics, vaccines, cell
and gene therapies, and sterile injectables. The Company’s flagship
Growth Direct System automates and modernizes the antiquated,
manual microbial quality control (“MQC”) testing workflows used in
the largest and most complex pharmaceutical manufacturing
operations across the globe. The Growth Direct System brings the
quality control lab to the manufacturing floor, unlocking the power
of MQC automation to deliver the faster results, greater accuracy,
increased operational efficiency, better compliance with data
integrity regulations, and quicker decision making that customers
rely on to ensure safe and consistent supply of important
healthcare products. The Company is headquartered and has U.S.
manufacturing in Lowell, Massachusetts, with global locations in
Lexington, Massachusetts, Switzerland, Germany, and the
Netherlands. For more information, please
visit www.rapidmicrobio.com or follow the Company on
Twitter at @rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Apr 2024 to May 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From May 2023 to May 2024